IVSXF (IVSXF) Stock Price & Analysis
IVSXF (IVSXF) fell 0.89% to USD 40.05 as of June 10, 2026 at 00:52 UTC, according to Nexqual real-time market data.
IVSXF last closed at USD 40.41; the session ranged USD 40.05–40.05 on volume of 100 shares. Market capitalization is $122.70B, with a 52-week range of USD 29.17–42.04 (PNK). Source: Nexqual, June 10, 2026 at 00:52 UTC.
Key Statistics (as of June 10, 2026 at 00:52 UTC)
| Price | USD 40.05 |
|---|---|
| Change | ▼ 0.89% (down) |
| Previous Close | USD 40.41 |
| Open | USD 40.05 |
| Day Range | USD 40.05 – 40.05 |
| 52-Week Range | USD 29.17 – 42.04 |
| Volume | 100 shares |
| Market Cap | $122.70B |
| Exchange | PNK |
Technical Analysis (IVSXF)
Nexqual's technical model rates IVSXF "BUY" based on 5 bullish and 1 bearish signals across 124 daily candles, as of June 10, 2026 at 00:52 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 53.14 (neutral) |
| vs SMA50 | Above (USD 39.29) |
| MACD | 0.32 (positive) |
Analyst Ratings (IVSXF)
Wall Street analysts rate IVSXF "None", per Nexqual as of June 10, 2026 at 00:52 UTC.
| Consensus Rating | None |
|---|
Earnings (IVSXF)
Source: Nexqual, June 10, 2026 at 00:52 UTC.
Financials & Fundamentals (IVSXF)
| Revenue Growth (YoY) | +357.30% |
|---|---|
| Gross Margin | +86.77% |
| Operating Margin | +0.00% |
| Profit Margin | +74.52% |
| ROE | +21.20% |
| Debt / Equity | 12.4 |
| Current Ratio | 3.51 |
| Free Cash Flow | $126.12B |
Source: Nexqual, June 10, 2026 at 00:52 UTC.
Financial Health Score (IVSXF)
Nexqual rates IVSXF's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:52 UTC.
| Growth | Critical — Revenue -14% YoY (annual), sharp decline |
|---|---|
| Profitability | Strong — Gross margin 87%, operating 0% |
| Balance Sheet | Strong — Debt/Equity 0.1x |
| Cash Flow | Strong — FCF $126.1B, 195% margin |
| Efficiency | Strong — ROE 21%, ROA 11.9% |
Ownership (IVSXF)
| Insider Ownership | +49.44% |
|---|---|
| Institutional Ownership | +29.61% |
| Shares Outstanding | 1.25B |
| Float | 2.44B |
Source: Nexqual, June 10, 2026 at 00:52 UTC.
Leadership (IVSXF)
IVSXF is led by Christian Cederholm (age 47), President, CEO, Director & Member of Management Board, per Nexqual as of June 10, 2026 at 00:52 UTC.
| President, CEO, Director & Member of Management Board | Christian Cederholm (age 47) |
|---|---|
| Chief Financial Officer | Jenny Ashman Haquinius (age 39) |
Major Backers & Investors (IVSXF)
Notable institutional backers of IVSXF include First Eagle Funds-First Eagle Global Fund, according to Nexqual as of June 10, 2026 at 00:52 UTC.
Active Investors
| Investor | Stake |
|---|---|
| First Eagle Funds-First Eagle Global Fund | 0.34% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.24% |
Source: Nexqual, June 10, 2026 at 00:52 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IVSBF | Investors AB | USD 41.09 | ▲ 4.26% |
| SMFNF | Sumitomo Mitsui Financial Group | USD 36.48 | ▼ 7.97% |
| KDDIF | KDDI Corp. | USD 15.2 | ▼ 9.52% |
| AXAHF | AXA | USD 46.7 | ▲ 1.52% |
| SHECF | Shin-Etsu Chemical Co., Ltd. | USD 46.5 | ▲ 7.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:52 UTC. This page is informational and not investment advice.